PAVmed Inc. Common Stock (PAVM) Stock Price

PAVMStock

$4.92−64.96%52W

Market Cap$39.34M

P/E79.62x

PEG Ratio—

Div yield—

Beta0.70

PAVM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-62.68%

Price vs S&P 500 (4W)-12.09%

VGM Score38.14

P/E Ratio (Annual)79.62x

Book Value / Share (Quarterly)$6.30

P/TBV (Annual)3.63x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-42.83%

Cash Flow / Share (Quarterly)$-1.00

Price vs S&P 500 (YTD)-38.50%

Gross Margin (TTM)-227.06%

Net Profit Margin (TTM)-21914.12%

EPS (TTM)$-28.72

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-28.72

EPS (Annual)$0.60

ROI (Annual)0.89%

Gross Margin (Annual)-207.04%

Net Profit Margin (5Y Avg)-6841.93%

Cash / Share (Quarterly)$1.09

P/E Basic Excl Extra (TTM)89.09x

Revenue Growth QoQ (YoY)175.00%

P/E Normalized (Annual)79.62x

ROA (Last FY)1.03%

Revenue Growth TTM (YoY)-95.74%

EBITD / Share (TTM)$-29.28

ROE (5Y Avg)-440.28%

Operating Margin (TTM)-32728.24%

Cash Flow / Share (Annual)$-5.64

P/B Ratio0.81x

P/B Ratio (Quarterly)1.62x

Net Income / Employee (Annual)$9,800

EV / Revenue (TTM)470.47x

Net Interest Coverage (TTM)-166.22x

ROA (TTM)-44.83%

EV / EBITDA (TTM)0.91x

EPS Incl Extra (Annual)$0.60

Current Ratio (Annual)0.17x

Quick Ratio (Quarterly)1.94x

3-Month Avg Trading Volume0.02M

52-Week Price Return-64.96%

P/E Incl Extra (TTM)89.09x

Revenue / Employee (TTM)$2,100

Tangible BV / Share (Quarterly)$0.05

P/S Ratio (Annual)449.71x

Asset Turnover (Annual)0.00x

52-Week High$28.44

Operating Margin (5Y Avg)-13979.48%

EPS Excl Extra (Annual)$0.60

CapEx CAGR (5Y)-12.37%

26-Week Price Return-50.75%

Quick Ratio (Annual)0.15x

13-Week Price Return-21.53%

Total Debt / Equity (Annual)0.33x

Current Ratio (Quarterly)2.02x

Enterprise Value$39.99M

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$1,700

Pretax Margin (Annual)-3477.46%

Cash / Share (Annual)$2.10

3-Month Return Std Dev90.93%

Gross Margin (5Y Avg)-260.22%

Net Income / Employee (TTM)$-454,300

ROE (Last FY)1.18%

Net Interest Coverage (Annual)-0.22x

EPS Basic Excl Extra (Annual)$0.60

Receivables Turnover (TTM)5.67x

Total Debt / Equity (Quarterly)0.38x

EPS Incl Extra (TTM)$-28.72

Receivables Turnover (Annual)4.30x

ROI (TTM)-39.26%

P/S Ratio (TTM)375.64x

Pretax Margin (5Y Avg)-8831.06%

Revenue / Share (Annual)$0.11

Tangible BV / Share (Annual)$0.69

Price vs S&P 500 (52W)-83.52%

P/E Ratio (TTM)89.09x

Year-to-Date Return-25.68%

5-Day Price Return-3.53%

EPS Normalized (Annual)$0.60

ROA (5Y Avg)-57.14%

Net Profit Margin (Annual)564.79%

Month-to-Date Return-0.61%

Cash Flow / Share (TTM)$-0.82

EBITD / Share (Annual)$-32.45

Operating Margin (Annual)-30794.37%

ROI (5Y Avg)-120.16%

P/E Excl Extra (TTM)89.09x

LT Debt / Equity (Quarterly)0.38x

EPS Basic Excl Extra (TTM)$-28.72

P/TBV (Quarterly)15.65x

P/B Ratio (Annual)0.19x

Inventory Turnover (TTM)34.81x

Pretax Margin (TTM)-26065.88%

Book Value / Share (Annual)$36.61

Price vs S&P 500 (13W)-23.49%

Beta0.70x

Revenue / Share (TTM)$0.05

ROE (TTM)-49.65%

52-Week Low$3.85

vGradeC

gGradeC

mGradeD

vgmGradeD

PAVM Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 14, 2026	-$0.63	-$0.27	+57.14%(+$0.36)
Q1 2026	May 15, 2026	-$0.69	-$1.17	-69.57%(-$0.48)
Q4 2025	Mar 30, 2026	-$4.50	-$1.05	+76.67%(+$3.45)
Q3 2025	Nov 13, 2025	-$6.00	-$0.60	+90.00%(+$5.40)
Q2 2025	Aug 14, 2025	-$7.50	-$1.50	+80.00%(+$6.00)

PAVM Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
PAVMPAVmed Inc. Common Stock	C	C	D	$4.92
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55

About PAVmed Inc. Common Stock

PAVmed Inc is a commercial-stage medical technology company developing products across diagnostics, medical devices, and digital health. Its portfolio includes EsoGuard, esocheck, and the Veris Cancer Care Platform. The company is advancing its pipeline through commercialization to serve multiple healthcare markets.